Carotid artery Doppler measurements in patients with polycystic ovary syndrome

Conclusion: Patients with PCOS are accepted to have a higher for atherosclerosis, and different doppler measurements may demonstrate the development of premature arteriosclerosis in these patients.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Objective: Polycystic ovary syndrome (PCOS) is seen in nearly 10% of women during reproductive age.

📊

Key Findings & Data:Materials and Methods: Fifteen patients with PCOS and 15 women with normal menstrual cycles were included in the study.

💡

Conclusion & Impact:Conclusion: Patients with PCOS are accepted to have a higher for atherosclerosis, and different doppler measurements may demonstrate the development of premature arteriosclerosis in these patients.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Ultrasonografi · doppler · Polikistik yumurtalık sendromu

Abstract

Objective: Polycystic ovary syndrome (PCOS) is seen in nearly 10% of women during reproductive age. Menstrual irregularity, hirsutism, and infertility are major complaints. Arteriosclerosis may be seen in patients with polycystic ovary syndrome (PCOS) due to atherogenic profile of these patients in the long run. Our goal in this study was to investigate carotid artery doppler measurements in these patients. Materials and Methods: Fifteen patients with PCOS and 15 women with normal menstrual cycles were included in the study. Right carotid artery doppler measurements were done by a radiologist blind to the diagnosis of the patients and the control group by using Hewlett-Packard image point 5-10 MHz doppler equipment. Carotid artery intima-media wall thickness was measured and the resistance indices S/D, PI and RI were calculated. Results: Carotid artery intima-media wall thickness was significantly thicker in patients with PCOS (P=0,049); all resistance indices were lower than that of the control group (P=0.003; P=0.001; P=0.005). Conclusion: Patients with PCOS are accepted to have a higher for atherosclerosis, and different doppler measurements may demonstrate the development of premature arteriosclerosis in these patients.

Özet

Amaç: Polikistik over sendromu (PKOS) üreme çağında yaklaşık %10 oranında görülen, adet düzensizliği, hirsutizm, infertilite gibi sorunlar ile seyreden bir rahatsızlıktır. Uzun vadeli komplikasyon olarak aterojenik kan profili sonucu arterioskleroz gelişebilir. Bu araştırmada PKOS tanısı almış kişilerde karotis arter doppler akım örneklerini araştırmayı amaçladık. Gereç ve Yöntem:Çalışmaya PKOS tanısı almış 15 hasta ile düzenli adet gören 15 kişi alındı. Tüm hastalara radyoloji kliniğinde hastanın tanısını bilmeyen bir doktor tarafından, Hewlett-Packard image point 5-10 mHz cihazın multilineer probu kullanılarak sağ karotis arter doppler incelemesi yapıldı. İnceleme sırasında damarın tunika intima-media arası mesafe ölçüldü ve arterden geçen kan akımının S/D, PI ve RI oranları hesaplandı. Bulgular:PKOS tansı alan hastalarda karotis arter tunika intima-media arası normal kişilere göre daha kalındı (P=0,049); damar direnci hakkında fikir veren S/D, PI ve RI değerleri ise azalmıştı (P=0.003; P=0.001; P=0.005). Sonuç:PKOS tanısı alan hastalarda erken yaşta ateroskleroz gelişimi için risk artabilir, bu hastalarda tespit edilen bu değişiklikler erken yaşta arterioskleroz gelişimi lehine yorumlanabilir.

Keywords

Ultrasonografi doppler Polikistik yumurtalık sendromu Karotis arterleri Ateroskleroz Ultrasonography Doppler Polycystic Ovary Syndrome Carotid Arteries Atherosclerosis

🔖

Cite This Article

KOYUNCU, F., KUŞCU, N. K., TARHAN, S., SERTER, S., YILMAZ, G., YILDIRIM, Y. (2003). Carotid artery Doppler measurements in patients with polycystic ovary syndrome. Medical Network Klinik Bilimler ve Doktor, Cilt: 9 - Sayı: 4, 488–490. https://ajindex.com/articles/278586

References (12)

Dunaif A, Segal KR, Futterweit W, Dobriansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 1989; 38:1165-74.
Ehrmann D, Struris J, Byrne M, Karrison T, Rosenfield R, Polonsky R. Insulin secretory defects in polycystic ovary syndrome: relationship to insulin sensitivity and family history of non-insulin dependent diabetes mellitus. J Clin Invest 1995; 96:520-7.
Wild RA, Painter PC, Coulson PB, Carrith KB, Ranney GB. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985;61:946-51.
Dahlgreen E, Janson P, Johansson S, Lapidus L, Oden A. Polycystic ovary syndrome and risk for myocardial infarctus. Aca Obstet Gynecol Scand 1992; 71:599-604. Franks S. N Engl J Med 1995; 333:853-61.
Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17a activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome N Engl J Med 1996; 335:617-23.
Mitwally MFM, Kuşçu NK, Yalçınkaya TM. High ovulatory rates with use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome. Hum Reprod 1999; 14:2700-3.
Guzick D, Talbott E, Sutton-Tyrell K, Herzog H, Küller L, Wolfson SJ. Carotid atheroclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am J Obstet Gynecol 1996; 174:1224-32.
Birdsall M, Farquhar C, White H. Association between polycystic ovaries and extent of coronary heart disese in women having cardiac catheterization Ann Intern Med 1997; 126:32-5.
Graf MJ, Richards CJ, Brown V, Meissner L, Dunaif A. The independent effects of hyperandrogenemia, hyperinsulinemia, and obesity on lipid and lipoprotein profiles in women. Clin Endocrinol 1990;33:119-31.
Talbott EO, Guzick DS, Sutton-Tyrrell K, et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vase Biol 2000; 20:2414-21.
Lakhani K, Constantinovici N, Purcell WM, Fernando R, Hardiman P. Internal carotid artery haemodynamics in women with polycystic ovaries. Clin Sci (Colch) 2000; 98:661-5.
Griffith DNW, Saimbi S, Lewis C, Tolfree S, Betteridge DJ Abnormal cerebrovascular carbon dioxide reactivity in people with diabetes. Diabetic Med. 1987; 4:217-20.